FDA Grants Authorization Allowing Research Institute to Study Psychedelic Use by Therapists
This comes after the FDA also recently allowed institutes to conduct clinical trials on MDMA and its therapeutic potential in treating PTSD.
Synthetic Psychedelic Reduces Stress in Mice, Study Finds
Crucially, the scientists say, the benefits of the drug came without the cost of hallucinations, a side effect which may aggravate stress.
The Ins and Outs of Psychedelic-Assisted Psychotherapy
Analytical Cannabis' sister publication, Technology Networks, explores the benefits of psychedelic-assisted therapy.
Drug-finding Tool Identifies Psychedelic-like Drug That Is Hallucination-free
A new technology developed by researchers at the University of California Davis promises to fast-track the development of compounds that could exploit psychedelics’ therapeutic action without hallucinogenic side effects.
Psilocybin Compared to Antidepressant in Breakthrough Trial
A new trial has directly compared the antidepressant effects of psilocybin with a more classical antidepressant, and found that the two are matched in their mood-altering potential.
Could a Chemical Flip Produce a More Effective Ketamine-based Antidepressant?
Drug developers say that R-ketamine could potentially deliver a more targeted action with fewer side effects than its more popular chemical twin.
Could the “Spirit Molecule” DMT Assist in Stroke Recovery?
N,N-dimethyltryptamine (DMT) is a psychedelic compound under investigation for a range of therapeutic uses. One avenue of research is being pursued by Algernon Pharmaceuticals, who are investigating whether sub-hallucinogenic DMT doses could help to protect and repair the brain in the hours after a stroke.
The Current State of Psychedelic Research
Scientific research groups have only begun investigating the properties of psychedelic compounds relatively recently. But what have they uncovered so far?
A Microdosing High is Mostly a Placebo Effect, Psychedelic Study Suggests
People may not have to microdose psychedelics to feel their wellbeing benefits – they just have to believe they’ve microdosed them, according to researchers from Imperial College London.
